Retatrutide

Retatrutide (LY3437943) is a novel triple agonist compound with activity at GLP-1, GIP, and glucagon receptors. It is being investigated for its metabolic and weight regulation research applications. BulkGLP supplies Retatrutide in sterile vials with third-party COAs. Research-use only.